Takeki Uehara

8PUBLICATIONS
66CO-AUTHORS
Biomolecular modelling and designInfectious diseasesMolecular targetsMajor global burdens of diseaseVenereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 15, 2026
Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the RSV L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus Infection.

|Apr 22, 2026
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial.

|Apr 28, 2025
Ensitrelvir as a novel treatment option for mild-to-moderate COVID-19: a narrative literature review.

Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari

|Feb 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.

Anne F Luetkemeyer, Kara W Chew, Stuart Lacey

|Jun 18, 2024
Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial.

Norio Ohmagari, Hiroshi Yotsuyanagi, Yohei Doi

|Feb 24, 2023
A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part).

Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi

Pageof 2

Frequent Collaborators

2 joint publications

Simon Portsmouth

2 joint publications

Methee Chayakulkeeree

2 joint publications

Courtney V Fletcher

1 joint publications

Alex Mann